SPRY1 and prostate carcinoma: In their in vitro study, the investigators interestingly observed that the prostate cancer cells LNCaP and PC3, in contrast to primary epithelial cells, did not show induction of the Spry1 expression at mRNA and protein levels in response to FGF2 stimulation.